Proliferative effects of CXC chemokines in rat hepatocytes in vitro and in vivo

Shock

Volumn 10, Issue 4, 1998, Pages 248-257

  Colletti, Lisa M ^a,b   Green, Maranne ^a   Burdick, Marie D ^a   Kunkel, Steven L ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANTIBODY; CXC CHEMOKINE IP 10; CXC CHEMOKINE IP-10; CXCL5 PROTEIN, HUMAN; CXCL9 PROTEIN, HUMAN; DRUG DERIVATIVE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGENIC AGENT; MONOKINE; SCATTER FACTOR; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LIVER; LIVER REGENERATION; LIVER RESECTION; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES; CELL DIVISION; CELLS, CULTURED; CHEMOKINES, CXC; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; LIVER; LIVER REGENERATION; MALE; MITOGENS; MONOKINES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032185642     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199810000-00004     Document Type: Article

References (35)

1. Weinbren K, Hadjis NS: Compensatory hyperplasia of the liver. In Blumgart LH (ed): Surgery of the Liver and Biliary Tract. Edinburgh, United Kingdom: Churchill Livingstone, 1990, pp 51-54.
2. Fausto N, Laird AD, Webber EM: Role of growth factors and cytokines in hepatic regeneration. FASEB J 9:1527-1536, 1996.
3. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI: Circulating tumor necrosis factor, interleukin-1, and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267-276, 1991.
4. Cressman DE, Greenbaum LE, DeAngelis RA, et al: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379-1383, 1996.
5. Yamada Y, Kirillova I, Peschon JJ, Fausto N: Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 94:1441-1446, 1997.
6. Rai RM, Loffreda S, Karp CL, Yang SQ, Lin HZ, Diehl AM: Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained over-expression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology 25:889-895, 1997.
7. Strieter RM, Polverini PJ, Kunkel SL, et al: The functional role of the ELR motif in CXC chemokine-mediate angiogenesis. J Biol Chem 270:27348-27357, 1995.
8. Strieter RM, Lukacs NW, Standiford TJ, Kunkel SL: Cytokines and lung inflammation. Thorax 48:765-769, 1993.
9. Berry MN, Friend DS: High-yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structural study. J Cell Biol 43:506-520, 1969.
10. Nakamura T, Tomita Y, Ichihara A: Density-dependent growth control of adult rat hepatocytes in primary culture. J Biochem 94:1029-1035, 1983.
11. Colletti LM, Kunkel SL, Walz A, et al: Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. J Clin Invest 95:134-141, 1995.
12. Colletti LM, Kunkel SL, Walz A, et al: The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 23:506-514, 1996.
13. Higgins GM, Anderson RM: Experimental pathology of the liver: Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12:186-202, 1931.
14. Colletti LM, Kunkel SL, Green M, Burdick M, Strieter RM: Hepatic inflammation following 70% hepatectomy may be related to up-regulation of epithelial neutrophil activating protein-78. Shock 6:397-402, 1996.
15. Colletti LM, Kunkel SL, Green M, Burdick MD, Strieter RM: Removal of the ischemic lobe following hepatic ischemia/reperfusion does not eliminate the pathophysiologic changes associated with hepatic ischemia/reperfusion. Shock 5:371-377, 1996.
16. Duval DL, Howard D, McCalden TA, Billings RE: The determination of myeloperoxidase activity in liver. Life Sci 47:PL145-PL150, 1990.
17. Feingold KR, Soued M, Grunfeld C: Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Commun 153:576-582, 1988.
18. Beyer HS, Stanley M: Tumor necrosis factor-α increases hepatic DNA and RNA and hepatocyte mitosis. Biochem Int 22:405-410, 1990.
19. Kubo Y, Yasunaga M, Masuhara M, Terai S, Nakamura T, Okita K: Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor-α inhibitors. Hepatology 23:104-114, 1996.
20. Diehl AM, Rai R: Review: Regulation of liver regeneration by proinflammatory cytokines. J Gastroenterol Hepatol 11:466-470, 1996.
21. Satoh M, Adachi K, Suda T, Yamazaki M, Mizuno D: TNF-driven inflammation during mouse liver regeneration after partial hepatectomy and its role in growth regulation of liver. Mol Biother 3:136-147, 1991.
22. Thornton AJ, Ham J, Kunkel SL: Kupffer cell-derived cytokines induce synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology 14:1-11, 1991.
23. Maruyama H, Harada A, Kurokawa T, et al: Duration of liver ischemia and hepatic regeneration after hepatectomy in rats. J Surg Res 58:290-294, 1995.
24. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr: Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85:1936-1943, 1990.
25. Colletti LM, Burtch GD, Remick DG, et al: The production of tumor necrosis factor-α and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 49:268-272, 1990.
26. Miller MD, Krangel MS: Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17-46, 1992.
27. Thornton AJ, Strieter RM, Lindley I, Baggiolini M, Kunkel SL: Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J Immunol 144:2609-2613, 1990.
28. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM: Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J Exp Med 174:1355-1362, 1991.
29. Driscoll KE, Hassenbein DG, Howard BW, et al: Cloning, expression, and functional characterization of rat MIP-2: A neutrophil chemoattractant and epithelial cell mitogen. J Leukocyte Biol 58:359-364, 1995.
30. Koch AE, Polverini PJ, Kunkel SL, et al: Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801, 1992.
31. Maione TE, Gray GS, Petro J, et al: Inhibition of angiogenesis by recombinant human platelet factor-4. Science 247:77-79, 1990.
32. Michel G, Kemeny L, Peter RU, et al: Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS Lett 305:241-243, 1992.
33. Herbert CA, Vitangcol RV, Baker JB: Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem 266:18989-18994, 1991.
34. Clark-Lewis I, Dewald B, Geiser T, Moser B, Baggiolini M: Platelet factor-4 binds to interleukin-8 receptors and activates neutrophils when its N-terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci USA 90:3574-3577, 1993.
35. Clark-Lewis I, Kim KS, Rajarathnam K, et al: Structure-activity relationships of chemokines. J Leukocyte Biol 57:703-711, 1995.